Abstract
Williams-Beuren syndrome (WBS) is a genetic, well-defined, rare, neurodevelopmental disorder characterized by intellectual disability, congenital heart defects, abnormal facial features, and growth, endocrine, and genitourinary abnormalities. The genitourinary abnormalities in WBS frequently include congenital structural renal defects, vesicoureteral reflux, nephrocalcinosis, proteinuria, and chronic renal insufficiency. Treatment of patients with posterior urethral valve (PUV) remains a clinical challenge, requiring long-term management from early infancy into adulthood in order to avoid progressive renal insufficiency. To my knowledge, this is the first worldwide case of WBS with PUV in a 12-year-old boy. Due to the delayed detection of the defect, chronic renal disease occurred as a risk for him. This case demonstrates the importance of early diagnosis of genitourinary anomalies such as PUV to prevent chronic renal disease in boys and especially in patients with WBS.
References
1.
Zarate
YA
, Lepard
T
, Sellars
E
, Kaylor
JA
, Alfaro
MP
, Sailey
C
, et al. Cardiovascular and genitourinary anomalies in patients with duplications within the Williams syndrome critical region: phenotypic expansion and review of the literature
. Am J Med Genet A
. 2014
;164A
(8
):1998
–2002
. .2.
Sugayama
SM
, Koch
VH
, Furusawa
EA
, Leone
C
, Kim
CA
. Renal and urinary findings in 20 patients with Williams-Beuren syndrome diagnosed by fluorescence in situ hybridization (FISH)
. Rev Hosp Clin Fac Med Sao Paulo
. 2004
;59
(5
):266
–72
. .3.
Sammour
ZM
, Gomes
CM
, de Bessa
J
Jr, Pinheiro
MS
, Kim
CA
, Hisano
M
, et al. Congenital genitourinary abnormalities in children with Williams-Beuren syndrome
. J Pediatr Urol
. 2014
;10
(5
):804
–9
. .4.
Pankau
R
, Partsch
CJ
, Winter
M
, Gosch
A
, Wessel
A
. Incidence and spectrum of renal abnormalities in Williams-Beuren syndrome
. Am J Med Genet
. 1996
;63
(1
):301
–4
. .5.
Sammour
ZM
, de Bessa
J
Jr, Hisano
M
, Bruschini
H
, Kim
CA
, Srougi
M
, et al. Lower urinary tract symptoms in children and adolescents with Williams-Beuren syndrome
. J Pediatr Urol
. 2017
;13
(2
):203.e1
–e6
. .6.
Sammour
ZM
, Gomes
CM
, Duarte
RJ
, Trigo-Rocha
FE
, Srougi
M
. Voiding dysfunction and the Williams-Beuren syndrome: a clinical and urodynamic investigation
. J Urol
. 2006
;175
(4
):1472
–6
. .7.
Ziylan
O
, Oktar
T
, Ander
H
, Korgali
E
, Rodoplu
H
, Kocak
T
. The impact of late presentation of posterior urethral valves on bladder and renal function
. J Urol
. 2006
;175
(5
):1894
–7
. .8.
Nwosu
BU
, Hopkins
TB
. Newborn with klinefelter syndrome and posterior urethral valves
. Urology
. 2008
;72
(5
):1033
–5
. .9.
Strand
WR
. Initial management of complex pediatric disorders: prunebelly syndrome, posterior urethral valves
. Urol Clin North Am
. 2004
;31
(3
):399
–415
. .10.
Sharma
S
, Joshi
M
, Gupta
D
, Abraham
M
, Mathur
P
, Mahajan
J
, et al. Consensus on the management of posterior urethral valves from antenatal period to puberty
. J Indian Assoc Pediatr Surg
. 2019
;24
(1
):4
–14
. .11.
Ansari
MS
, Singh
P
, Mandhani
A
, Dubey
D
, Srivastava
A
, Kapoor
R
, et al. Delayed presentation in posterior urethral valve: long-term implications and outcome
. Urology
. 2008
;71
(2
):230
–4
. .12.
Özen
M
, Taşdemir
M
, Gündoğdu
G
, Bilge
I
, Büyükünal
C
, Eroğlu
E
. Does voiding cystourethrogram exclude posterior urethral valves in late presenting cases?
Eur J Pediatr Surg
. 2019
;29
(01
):85
–9
. .© 2020 S. Karger AG, Basel
2020
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
